Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial

Vrieling, Conny; van Werkhoven, Erik; Maingon, P.; Poortmans, Philip; Weltens, Caroline; Fourquet, Alain; A.X. Schinagl, Dominic; Oei, Bing; Rodenhuis, C.C.; Horiot, Jean-Claude; Struikmans, H.; Van Limbergen, Erik; Kirova, Youlia; H.M. Elkhuizen, Paula; Bongartz, Rudolf; Miralbell, Raymond; Morgan, D.A.L.; Dubois, Jean‐Bernard; Remouchamps, Vincent; Mirimanoff, René‐Olivier; Hart, Guus; Collette, Sandra; Collette, Laurence; Bartelink, Harry

doi:10.1001/jamaoncol.2016.3031

Public

Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial

Published in JAMA Oncology • Sep 8, 2016

Authors:

Conny Vrieling

Erik van Werkhoven

P. Maingon

Abstract

IMPORTANCE: Prognostic factors of ipsilateral breast tumor recurrence (IBTR) may change over time following breast-conserving therapy. OBJECTIVE: The EORTC "boost no boost" trial showed that young age and high-grade invasive carcinoma were the most important risk factors for IBTR. This study reanaly...

Subject

Medicine

Cumulative incidence

Breast cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!